Sale!

CLCN7 Gene Osteopetrosis Autosomal Recessive Type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLCN7 Gene Osteopetrosis Autosomal Recessive Type 4 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the CLCN7 gene, which are responsible for Autosomal Recessive Osteopetrosis Type 4 (ARO4). Osteopetrosis is a rare bone disease characterized by the abnormal density and structuring of bones, leading to various health complications such as fractures, anemia, and impaired growth. The test is crucial for early diagnosis, enabling targeted treatment and management strategies for affected individuals.

This genetic test involves analyzing the patient’s DNA to identify mutations in the CLCN7 gene, which plays a significant role in bone resorption and growth. By pinpointing specific genetic alterations, healthcare providers can confirm a diagnosis of ARO4, differentiate it from other types of osteopetrosis and related bone disorders, and guide families regarding the inheritance patterns and risks for future children.

The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret the genetic variations associated with this condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test adheres to stringent quality and accuracy standards, ensuring reliable results for patients and their families.

Description

CLCN7 Gene Osteopetrosis Autosomal Recessive Type 4 Genetic Test

Test Name: CLCN7 Gene Osteopetrosis Autosomal Recessive Type 4 Genetic Test

Components: CLCN7 Gene Osteopetrosis Autosomal Recessive Type 4 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CLCN7 Gene Osteopetrosis, Autosomal Recessive Type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CLCN7 Gene Osteopetrosis, Autosomal Recessive Type 4 NGS Genetic DNA Test gene CLCN7.

Test Details: The CLCN7 gene is associated with a condition called osteopetrosis, which is a rare genetic disorder characterized by increased bone density and brittle bones. Autosomal recessive type 4 refers to a specific subtype of osteopetrosis caused by mutations in the CLCN7 gene. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for a comprehensive evaluation of a patient’s genetic makeup. In the case of osteopetrosis, an NGS genetic test can identify mutations in the CLCN7 gene that may be responsible for the condition. By identifying specific mutations in the CLCN7 gene, NGS genetic testing can help confirm a diagnosis of autosomal recessive type 4 osteopetrosis. It can also provide information about the specific genetic variant present, which can be useful for genetic counseling and family planning. It is important to note that genetic testing should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name	CLCN7 Gene Osteopetrosis autosomal recessive type 4 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CLCN7 Gene Osteopetrosis, autosomal recessive type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CLCN7 Gene Osteopetrosis, autosomal recessive type 4 NGS Genetic DNA Test gene CLCN7
Test Details	The CLCN7 gene is associated with a condition called osteopetrosis, which is a rare genetic disorder characterized by increased bone density and brittle bones. Autosomal recessive type 4 refers to a specific subtype of osteopetrosis caused by mutations in the CLCN7 gene. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for a comprehensive evaluation of a patient’s genetic makeup. In the case of osteopetrosis, an NGS genetic test can identify mutations in the CLCN7 gene that may be responsible for the condition. By identifying specific mutations in the CLCN7 gene, NGS genetic testing can help confirm a diagnosis of autosomal recessive type 4 osteopetrosis. It can also provide information about the specific genetic variant present, which can be useful for genetic counseling and family planning. It is important to note that genetic testing should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.